Urokinase in thromboembolic disease: Pulmonary embolism.
D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D004359:Drug Therapy, Combination; D010450:Endopeptidases / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D006493:Heparin; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator